Abstract Psoriasis affects approximately 0.3% of the Japanese population. Recently, various
effective systemic drugs have become available, and the continuation of a given treatment …

Despite product monograph warnings of post-retinoid sexual dysfunction (PRSD) for
isotretinoin and recent policy decisions regarding the safety of isotretinoin, this study …

Psoriasis is a chronic autoimmune disease characterized by hyperproliferation of
keratinocytes and appearance of thick silver patches and redness on the scalp, knees …

Etretinate, an acitretin metabolite, has a long retention duration in adipose tissues with a
teratogenic potential. FDA advises a contraceptive period of at least three years after …

Objective: Acitretin is a widely used systemic retinoid that is to treat psoriasis but has
significant variations in efficacy and adverse events (AEs) among individuals. This study …

There is an increasing need for appropriate effective treatment and long-term disease
control in patients with psoriasis because of the decreased quality of life, increased …

Psoriasis is a chronic, recurrent, autoimmune skin disease. In Croatia, around 80,000
people have some form of psoriasis, and 20% have moderate or severe psoriasis. The total …